Pain; Bone Neoplasms; Neoplasm Metastasis Clinical Trial
Official title:
An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Bone Pain in Patients With Breast Cancer and Skeletal Metastases
This single arm study will assess the efficacy and safety of loading doses of intravenous Bondronat in patients with breast cancer and malignant bone disease experiencing moderate to severe bone pain. Patients will receive an intravenous infusion of 6mg Bondronat on days 1, 2 and 3. The anticipated time on study treatment is 3 months, and the target sample size is <100 individuals.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02564107 -
A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease
|
Phase 4 | |
| Completed |
NCT02553707 -
A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer
|
Phase 4 | |
| Completed |
NCT02561039 -
A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease
|
Phase 3 |